Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Rsf Breaks Out Energy Leads Market Higher 20260401 1 Consumer Sentiment Plunges to Record Low as Iran War Drives Gas Prices Higher Teva Pharmaceutical TEVA Reports Q1 Beat Unveils Amylyx Deal Plans Cambium CMBM Stock Steady at 040 Support at 038 20260515 Insteel Industries IIIN Q1 2026 Results Fall Short EPS 027 Revenue NA ASEAN Manufacturers Reduce Workforce Amid Deepening Iran Conflict Impact Oil Prices Edge Higher as USIran Negotiations Show Slow Progress Puig Shares Slide After Este Lauder Merger Talks Collapse European Markets Edge Higher Wix Announces 20 Workforce Reduction Amid AI Integration Push Paytms Parent One 97 Communications Sees Rs 964 Crore Block Deal Institutional Investors Step In Nigel Farage Under Pressure to Substantiate Russian Hack Claim Over Cryptocurrency Gift PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises MS Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CNP Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Edges Higher EQH Q1 2026 Earnings Slightly Misses Estimates on EPS IIIN Q1 2026 Earnings EPS Falls Short of Estimates Amid Persistent Market Challenges Codexis Inc CDXS Climbs 44 as Shares Approach Key Resistance GDS Holdings Holds Steady Near 35 as Support and Resistance Levels Remain in Focus Orchestra BioMed OBIO Edges Higher Navigating Key Support and Resistance Levels MIND Technology MIND Slips 195 Key Support Levels Under Scrutiny RPC Inc RES Declines 4 as Energy Sector Weakness Pressures Stock FormFactor Inc FORM Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally CMCT Q3 2024 Earnings Significant EPS Miss Highlights Challenges Yet Stock Advances APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly Vista Gold Corp Q1 2026 Earnings Minimal Cash Burn Amid Mt Todd Project Advancements ORI Q1 2026 Earnings EPS Misses Estimates as Operating Environment Challenges Persist TransCode Therapeutics Q4 2024 Earnings WiderthanExpected Loss Reflects ClinicalStage Investment